Key result
Recently identified neurohormonal pathways are emerging as potential therapeutic targets for the treatment of chronic heart failure.
This review highlights emerging neurohormonal pathways that could serve as future therapeutic targets for chronic heart failure.
Does not yet warrant clinical use in chronic heart failure; leaves open novel neurohormonal targets for prospective trials.
Despite considerable therapeutic advances over recent years, chronic heart failure remains associated with significant morbidity and mortality. Further improvements in the treatment of this syndrome are therefore needed and this will require advances in the understanding of its underlying pathophysiology. This article reviews the literature regarding recently identified neurohormonal pathways that are declaring themselves as potential therapeutic targets in chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Dalzell et al. (2010) conducted a review in Chronic heart failure. Neurohormonal pathways was evaluated. Recently identified neurohormonal pathways are emerging as potential therapeutic targets for the treatment of chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: